Submit Deal

CASTLE BIOSCIENCES INC

HQ - Friendswood, TX

Summary

Castle Biosciences is a biotechnology company specializing in diagnostic and prognostic tests for dermatologic cancers and other diseases.

Deals Overview

Total Deals4

Valued Deals3

Total Value£ 190 M

Avg. Deal Size£ 63 M

Market Context

Senior Management

Derek Maetzold
CEO
Frank Stokes
CFO
Allison Marshall
Media Contact

Sort

20 Oct 2021|United States|Pharmaceuticals

Target: CERNOSTICS

Bidder: CASTLE BIOSCIENCES INC

3 Service Providers

1 Target | 2 Bidder

18 Dealmakers

1 Target | 17 Bidder

£ 59 M

Value

04 Apr 2022|United States|Biotechnology

Target: ALTHEADX

Bidder: CASTLE BIOSCIENCES INC

3 Service Providers

1 Target | 2 Bidder

6 Dealmakers

2 Target | 4 Bidder

£ 106 M

Value

05 May 2025|United States|Biotechnology

Target: PREVISE

Bidder: CASTLE BIOSCIENCES INC

3 Service Providers

1 Target | 2 Bidder

24 Dealmakers

1 Target | 23 Bidder

n/a

Value

27 Apr 2021|United States|Biotechnology

Target: MYRIAD MYPATH MELANOMA LLC

Bidder: CASTLE BIOSCIENCES INC

3 Service Providers

2 Bidder | 1 Vendor

4 Dealmakers

3 Bidder | 1 Vendor

£ 22 M

Value